Skip to Content
Merck
All Photos(1)

Documents

527769

Sigma-Aldrich

4-Phenoxybenzonitrile

96%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
C6H5OC6H4CN
CAS Number:
Molecular Weight:
195.22
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:

Assay

96%

mp

42-46 °C (lit.)

SMILES string

N#Cc1ccc(Oc2ccccc2)cc1

InChI

1S/C13H9NO/c14-10-11-6-8-13(9-7-11)15-12-4-2-1-3-5-12/h1-9H

InChI key

UYHCIOZMFCLUDP-UHFFFAOYSA-N

Gene Information

human ... MMP3(4314)

General description

4-Phenoxybenzonitrile can be prepared from the tris(3,6-dioxaheptyl)amine-catalyzed nucleophilic aromatic substitution reaction of 4-chlorobenzonitrile with phenol. It can also be prepared by reacting 4-cyanophenol, iodobenzene and CsF/Clinoptilolite (CsF/CP) in DMSO.

Application

4-Phenoxybenzonitrile may be used to synthesize 5-(4-phenoxy)phenyltetrazole.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

230.0 °F - closed cup

Flash Point(C)

110 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

CsF/clinoptilolite: an efficient solid base in SNAr and copper-catalyzed Ullmann reactions.
Keipour H, et al.
Canadian Journal of Chemistry, 94(1), 95-104 (2015)
Tris (polyoxaalkyl) amines (trident), a new class of solid-liquid phase-transfer catalysts.
Soula G.
The Journal of Organic Chemistry, 50(20), 3717-3721 (1985)
Gaston H Vondenhoff et al.
Chembiochem : a European journal of chemical biology, 13(13), 1959-1969 (2012-08-01)
In 1998, Cubist Pharmaceuticals patented a series of aminoacyl tRNA synthetase (aaRS) inhibitors based on aminoacyl sulfamoyladenosines (aaSAs), in which the adenine was substituted by aryl-tetrazole moieties linked to the ribose fragment by a two-carbon spacer. Although potent and specific

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service